Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
134 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

JP Morgan Initiates Coverage On CubeSmart with Neutral Rating, Announces $32 Price Target

By Vick Meyer
Today, 10:46 AM
JP Morgan analyst Michael Mueller initiates coverage on CubeSmart (NYSE:CUBE) with a Neutral rating and a $32 price…

CUBE

Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

Wells Fargo Upgrades Bausch Health Companies to Equal-Weight

By Vick Meyer
Today, 10:46 AM
Wells Fargo analyst Jacob Hughes upgrades Bausch Health Companies (TSX:BHC) from Underweight to Equal-Weight.

TSX:BHC

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target

By Vick Meyer
Today, 10:46 AM
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.

AGN

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Credit Suisse Downgrades Yiren Digital to Underperform

By Vick Meyer
Today, 10:46 AM
Credit Suisse analyst Yirendai Zhong downgrades Yiren Digital (NYSE:YRD) from Neutral to Underperform.

YRD

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News

DA Davidson Initiates Coverage On SciPlay with Buy Rating

By Vick Meyer
Today, 10:46 AM
DA Davidson analyst Franco Granda initiates coverage on SciPlay (NASDAQ:SCPL) with a Buy rating.

SCPL

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Credit Suisse Downgrades Qudian to Neutral

By Vick Meyer
Today, 10:46 AM
Credit Suisse analyst Charles Zhou downgrades Qudian (NYSE:QD) from Outperform to Neutral.

QD

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Stifel Nicolaus Downgrades Lilis Energy to Hold

By Vick Meyer
Today, 10:46 AM
Stifel Nicolaus analyst Michael Scialla downgrades Lilis Energy (AMEX:LLEX) from Buy to Hold.

LLEX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

Goldman Sachs Upgrades Coca-Cola Femsa to Buy

By Vick Meyer
Today, 10:46 AM
Goldman Sachs analyst Luca Cipiccia upgrades Coca-Cola Femsa (NYSE:KOF) from Neutral to Buy.

KOF

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Estee Lauder Cos to Neutral, Raises Price Target to $230

By Vick Meyer
Today, 10:46 AM
Citigroup analyst Wendy Nicholson downgrades Estee Lauder Cos (NYSE:EL) from Buy to Neutral and raises the price target…

EL

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

JMP Securities Initiates Coverage On Cue Biopharma with Market Outperform Rating, Announces $22 Price Target

By Vick Meyer
Today, 10:46 AM
JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a…

CUE

Posts navigation

Previous 1 … 10 11 12 … 14 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service